Eris Lifesciences Limited (ERIS-NS) Stock Split, History Data
Working capital analysis
In terms of working capital, Eris Lifesciences Limited maintains a healthy position.
The total current assets of the company are valued at $7647220000.
This represents a growth rate of 21.901% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $560220000, exhibiting a growth rate of 10.293% year-on-year.
The receivables, another significant portion of the current assets, are valued at $2966950000.
The year-on-year growth rate for receivables is 31.227%.
The inventory, which forms a critical part of the assets, is valued at $1314350000.
This represents a healthy year-on-year growth of 11.470%
On the liabilities side, the company's current liabilities total $4432330000.
This reflects a growth rate of 122.009% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
560.22
507.94
368.70
672.11
75.00
106.08
Receavebles
2966.95
2260.93
2280.61
2076.45
1760.37
1287.51
Inventory
1314.35
1179.11
944.66
694.75
826.53
654.48
Other
2473.49
1060.85
922.50
2681.50
6.47
1.11
Total Current Assets
7647.22
6273.30
4670.46
4796.17
5817.79
2987.07
Acc Payable
1247.69
1177.74
1026.16
1000.51
841.25
0.00
Short Term Debt
1932.90
40.13
23.30
59.99
1761.30
1026.04
Other Current Liab
217.22
152.37
132.46
162.08
181.41
1228.56
Current Liabilities
4432.33
1996.46
1669.31
1646.90
3055.37
2254.60
Capital Structure
When examining the capital structure of Eris Lifesciences Limited, it is clear that the company manages a robust portfolio.
These earnings represent the profits that Eris Lifesciences Limited has chosen to reinvest in the business rather than distribute as dividends.
